Viewing Study NCT00483067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-07-02 @ 11:28 AM
Study NCT ID: NCT00483067
Status: COMPLETED
Last Update Posted: 2012-08-02
First Post: 2007-06-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Idiopathic Hypereosinophilic Syndrome View
None Leukemia View
None 2-Chlorodeoxyadenosine View
None Cladribine View
None Cytarabine View
None Ara-C View
None 2-CdA View
None G-CSF View
None HES View